Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT04790786
What this trial is testing

UPMC OPTIMISE-C19 Trial, a COVID-19 Study

Who this might be right for
Covid19
Erin McCreary 4,571
Not applicableWithdrawnNCT04529460
What this trial is testing

Healthy Volunteer COVID-19 Antibody Testing Study

Who this might be right for
Covid19
Royal Free Hospital NHS Foundation Trust
Not applicableUnknownNCT05394623
What this trial is testing

Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)

Who this might be right for
Hepatitis DHepatitis BAntibodies; Anti-D+1 more
The First Affiliated Hospital with Nanjing Medical University 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05877508
What this trial is testing

Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)

Who this might be right for
Long COVIDPost-Acute Sequela of COVID-19Post-Acute COVID-19
Michael Peluso, MD 36
Early research (Phase 1)Study completedNCT04985760
What this trial is testing

Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy

Who this might be right for
HIV Infections
Madhu Chhanda Choudhary 32
Early research (Phase 1)Study completedNCT04932850
What this trial is testing

Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.

Who this might be right for
COVID-19 Virus Disease
Toscana Life Sciences Sviluppo s.r.l. 30
Early research (Phase 1)Study completedNCT03478891
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 19
Not applicableUnknownNCT05258708
What this trial is testing

COVID-19 Vaccine Reactogenicity and Immunogenicity

Who this might be right for
COVID-19Vaccine Immune ResponseVaccine Adverse Reaction
Korea University Guro Hospital 179
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Early research (Phase 1)Study completedNCT00002016
What this trial is testing

A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Sandoz
Not applicableUnknownNCT04470414
What this trial is testing

COVID-19 IgG Antibodies in the Serum of Recovered Patients

Who this might be right for
Covid19
Assiut University 100
Early research (Phase 1)Study completedNCT01403792
What this trial is testing

A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Who this might be right for
Human Immunodeficiency Virus
University of Surrey 11
Not applicableStudy completedNCT06085547
What this trial is testing

Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva

Who this might be right for
SARS-CoV2 Infection
Michigan State University 264
Testing effectiveness (Phase 2)WithdrawnNCT04144335
What this trial is testing

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

Who this might be right for
HivHIV/AIDSHIV Infections+3 more
University of Minnesota
Post-approval studies (Phase 4)Study completedNCT00329576
What this trial is testing

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 632
Testing effectiveness (Phase 2)Study completedNCT00322049
What this trial is testing

A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants

Who this might be right for
Dengue
U.S. Army Medical Research and Development Command 51
Not applicableStudy completedNCT04530682
What this trial is testing

COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs

Who this might be right for
Chronic Inflammatory Rheumatism
University Hospital, Montpellier 163
Not applicableStudy completedNCT05057910
What this trial is testing

SARS-CoV-2 (Covid-19) RBD Antibody in My Duc Hospital Healthcare Workers

Who this might be right for
Covid19Vaccine Reaction
Mỹ Đức Hospital 645
Not applicableStudy completedNCT05074368
What this trial is testing

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

Who this might be right for
Healthy Adult Volunteers
National Taiwan University Hospital 499
Not applicableStudy completedNCT00219999
What this trial is testing

Hepatitis C Virus and the Humoral Immune System

Who this might be right for
Hepatitis C Virus
Rockefeller University 161
Next Page